BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19222228)

  • 1. Use of divalent metal ions in the dna cleavage reaction of human type II topoisomerases.
    Deweese JE; Burch AM; Burgin AB; Osheroff N
    Biochemistry; 2009 Mar; 48(9):1862-9. PubMed ID: 19222228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metal ion interactions in the DNA cleavage/ligation active site of human topoisomerase IIalpha.
    Deweese JE; Guengerich FP; Burgin AB; Osheroff N
    Biochemistry; 2009 Sep; 48(38):8940-7. PubMed ID: 19697956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human topoisomerase IIalpha uses a two-metal-ion mechanism for DNA cleavage.
    Deweese JE; Burgin AB; Osheroff N
    Nucleic Acids Res; 2008 Sep; 36(15):4883-93. PubMed ID: 18653531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of divalent metal ions in the DNA cleavage reaction of topoisomerase IV.
    Pitts SL; Liou GF; Mitchenall LA; Burgin AB; Maxwell A; Neuman KC; Osheroff N
    Nucleic Acids Res; 2011 Jun; 39(11):4808-17. PubMed ID: 21300644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of the C-terminal domain on the interaction of human DNA topoisomerase II α and β with DNA.
    Gilroy KL; Austin CA
    PLoS One; 2011 Feb; 6(2):e14693. PubMed ID: 21358820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming target-mediated quinolone resistance in topoisomerase IV by introducing metal-ion-independent drug-enzyme interactions.
    Aldred KJ; Schwanz HA; Li G; McPherson SA; Turnbough CL; Kerns RJ; Osheroff N
    ACS Chem Biol; 2013 Dec; 8(12):2660-8. PubMed ID: 24047414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of divalent metal ions by type II topoisomerases.
    Deweese JE; Osheroff N
    Metallomics; 2010 Jul; 2(7):450-9. PubMed ID: 20703329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using 3'-bridging phosphorothiolates to isolate the forward DNA cleavage reaction of human topoisomerase IIalpha.
    Deweese JE; Burgin AB; Osheroff N
    Biochemistry; 2008 Apr; 47(13):4129-40. PubMed ID: 18318502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of cysteine residue 455 to alanine in human topoisomerase IIalpha confers hypersensitivity to quinones: enhancing DNA scission by closing the N-terminal protein gate.
    Bender RP; Osheroff N
    Chem Res Toxicol; 2007 Jun; 20(6):975-81. PubMed ID: 17516663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bimodal recognition of DNA geometry by human topoisomerase II alpha: preferential relaxation of positively supercoiled DNA requires elements in the C-terminal domain.
    McClendon AK; Gentry AC; Dickey JS; Brinch M; Bendsen S; Andersen AH; Osheroff N
    Biochemistry; 2008 Dec; 47(50):13169-78. PubMed ID: 19053267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catalytic core of human topoisomerase IIα: insights into enzyme-DNA interactions and drug mechanism.
    Lindsey RH; Pendleton M; Ashley RE; Mercer SL; Deweese JE; Osheroff N
    Biochemistry; 2014 Oct; 53(41):6595-602. PubMed ID: 25280269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation P732L in human DNA topoisomerase IIbeta abolishes DNA cleavage in the presence of calcium and confers drug resistance.
    Leontiou C; Lakey JH; Lightowlers R; Turnbull RM; Austin CA
    Mol Pharmacol; 2006 Jan; 69(1):130-9. PubMed ID: 16239602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical characterization of human tyrosyl-DNA phosphodiesterase 2 (TDP2/TTRAP): a Mg(2+)/Mn(2+)-dependent phosphodiesterase specific for the repair of topoisomerase cleavage complexes.
    Gao R; Huang SY; Marchand C; Pommier Y
    J Biol Chem; 2012 Aug; 287(36):30842-52. PubMed ID: 22822062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordinating the two protomer active sites of human topoisomerase IIalpha: nicks as topoisomerase II poisons.
    Deweese JE; Osheroff N
    Biochemistry; 2009 Feb; 48(7):1439-41. PubMed ID: 19166355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the C-terminal domain of topoisomerase IIalpha on the DNA cleavage activity of the human enzyme.
    Dickey JS; Osheroff N
    Biochemistry; 2005 Aug; 44(34):11546-54. PubMed ID: 16114891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The geometry of DNA supercoils modulates topoisomerase-mediated DNA cleavage and enzyme response to anticancer drugs.
    McClendon AK; Osheroff N
    Biochemistry; 2006 Mar; 45(9):3040-50. PubMed ID: 16503659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA cleavage and opening reactions of human topoisomerase IIα are regulated via Mg2+-mediated dynamic bending of gate-DNA.
    Lee S; Jung SR; Heo K; Byl JA; Deweese JE; Osheroff N; Hohng S
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2925-30. PubMed ID: 22323612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human topoisomerase IIalpha possesses an intrinsic nucleic acid specificity for DNA ligation. Use of 5' covalently activated oligonucleotide substrates to study enzyme mechanism.
    Bromberg KD; Hendricks C; Burgin AB; Osheroff N
    J Biol Chem; 2002 Aug; 277(34):31201-6. PubMed ID: 12050172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cobalt enhances DNA cleavage mediated by human topoisomerase II alpha in vitro and in cultured cells.
    Baldwin EL; Byl JA; Osheroff N
    Biochemistry; 2004 Jan; 43(3):728-35. PubMed ID: 14730977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exocyclic DNA lesions stimulate DNA cleavage mediated by human topoisomerase II alpha in vitro and in cultured cells.
    Vélez-Cruz R; Riggins JN; Daniels JS; Cai H; Guengerich FP; Marnett LJ; Osheroff N
    Biochemistry; 2005 Mar; 44(10):3972-81. PubMed ID: 15751973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.